CD96 and head and neck squamous cell carcinoma: To test whether anti-CD96 mAbs are capable of costimulating TILs, we isolated lymphocytes from HPV+ HNSCC tumors and measured T cell proliferation in response to plate-bound anti-CD3 and anti-CD96.